We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

102 hedge funds and large institutions have $311M invested in iShares US Pharmaceuticals ETF in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

425% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 4

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

20% more capital invested

Capital invested by funds: $259M → $311M (+$52.1M)

19% more funds holding

Funds holding: 86 → 102 (+16)

6.69% more ownership

Funds ownership: 105.34% → 112.03% (+6.7%)

3% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 30

Holders
102
Holders Change
+16
Holders Change %
+18.6%
% of All Funds
2.72%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
21
Increased
31
Reduced
30
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Brookstone Capital Management
Illinois
+$15.1M
2
BWM
Braver Wealth Management
Massachusetts
+$11.9M
3
Citadel Advisors
Citadel Advisors
Florida
+$4.2M
4
Wells Fargo
Wells Fargo
California
+$3.46M
5
SG Americas Securities
SG Americas Securities
New York
+$2.83M

Top Sellers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$12.1M
2
RJA
Raymond James & Associates
Florida
-$2.76M
3
TRCT
Tower Research Capital (TRC)
New York
-$2.6M
4
Bank of America
Bank of America
North Carolina
-$2.3M
5
Morgan Stanley
Morgan Stanley
New York
-$810K
Name Holding Trade Value Shares
Change 		Change in
Stake
CWM
76
Concert Wealth Management
California
$257K -$1.75K -36 -0.7%
BCA
77
Bray Capital Advisors
Florida
$246K +$238K +4,875 New
BHB
78
Bank Hapoalim BM
Israel
$234K – – –
EWM
79
Edge Wealth Management
New York
$233K -$40.9K -840 -15%
MFS
80
MSI Financial Services
Massachusetts
$231K +$22.5K +462 +11%
B
81
Baird
Wisconsin
$212K -$11.7K -240 -5%
SIG
82
Stanford Investment Group
California
$212K +$205K +4,203 New
Janney Montgomery Scott
83
Janney Montgomery Scott
Pennsylvania
$209K +$202K +4,143 New
BBA
84
BLB&B Advisors
Pennsylvania
$204K +$197K +4,050 New
AFG
85
Arkansas Financial Group
Arkansas
$196K -$59.2K -1,215 -24%
Bessemer Group
86
Bessemer Group
New Jersey
$91K – – –
GI
87
Gradient Investments
Minnesota
$72K – – –
RMAM
88
Raab & Moskowitz Asset Management
New Jersey
$70K +$67.2K +1,380 New
PNC Financial Services Group
89
PNC Financial Services Group
Pennsylvania
$60K – – –
AP
90
Advisors Preferred
Maryland
$49.2K -$147K -3,024 -76%
DSC
91
Duncker Streett & Co
Missouri
$45K – – –
ASN
92
Advisory Services Network
Georgia
$43K +$40.2K +825 New
WTC
93
WhitTier Trust Company
Nevada
$38K – – –
GWS
94
Glassman Wealth Services
Virginia
$23K +$21.9K +450 New
BRWM
95
B. Riley Wealth Management
Tennessee
$18K – – –
NFG
96
Next Financial Group
Texas
$15K -$440K -9,021 -97%
Citigroup
97
Citigroup
New York
$15K – – –
HNB
98
Huntington National Bank
Ohio
$15K – – –
TWA
99
TCI Wealth Advisors
Arizona
$15K – – –
BC
100
Bartlett & Co
Ohio
$5K – – –
1 2 3
4
5

IHE Hedge Fund Activity: Q4 2014 in Review

102 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q4 2014, worth a combined $311M — up 20% from $259M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new IHE positions and 4 closed out — a net gain of 17 holders — while 31 added to existing stakes and 30 trimmed.

The largest buyer was Brookstone Capital Management, opening a new position worth an estimated $15.1M. The largest seller was Bank of Montreal, cutting an estimated $12.1M.

  • 102 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q4 2014, up from 86 in Q3 2014.
  • Funds reported $311M of iShares US Pharmaceuticals ETF stock for Q4 2014, up 20% quarter-over-quarter.
  • 21 funds opened new iShares US Pharmaceuticals ETF positions in Q4 2014 and 4 closed out, a net change of +17 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q4 2014 was Brookstone Capital Management, an estimated $15.1M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q4 2014 was Bank of Montreal, an estimated $12.1M sold.

Based on aggregated 13F filings for Q4 2014.